Venlafaxine (SNRI)
Treatment for Anxiety Disorder
Typical Dosage: 75-225mg daily
Effectiveness
75%
Safety Score
60%
Clinical Trials
4
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
75-225mg daily
Time to Effect
2-4 weeks
Treatment Duration
6-12 months, often longer
Evidence Quality
HIGHNumber Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
9(Treat 9 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$400
Monitoring:$200
Side Effect Mgmt:$120
Total Annual:$720
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$55,000/QALY
QALYs Gained
0.23
Outcome-Based Costs
Cost per Responder
$1,309
Cost per Remission
$2,400
Comparison vs No Treatment
Cost Difference
+$720/year
More expensive
QALY Difference
+0.23 QALYs
Better outcomes
Dominance
No dominance
Venlafaxine (SNRI) Outcomes
for Anxiety Disorder
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+55%
Remission Rate
+30%
Common Side Effects
Nausea
+25%
Dizziness
+15%
Sweating
+18%
Sexual dysfunction
+25%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
3 completed trials for Venlafaxine (SNRI) in Anxiety Disorder
Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
NCT00183274COMPLETEDPHASE4
268 participants
INTERVENTIONAL
Philadelphia, United States
Started: Jan 1, 2004
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
NCT04478526COMPLETEDNA
115 participants
INTERVENTIONAL
Kingston, Canada
Started: Apr 29, 2020
Anxiety and Depression in Epilepsy: A Treatment Study
NCT03464383COMPLETEDPHASE4
69 participants
INTERVENTIONAL
Winston-Salem, United States
Started: May 7, 2018